Cholesterol & Lipid
Sort by:
Novartis Cardiology
Initiating and Monitoring Patients on a Non-Statin Lipid-Lowering Therapy: Provider Experiences
- 532 views
- August 30, 2024
- 1
3rd Annual Montefiore Einstein Preventive Cardiology Conference
Optimizing Diet for Prevention and Treatment
FEATURING
Walter Willett
- 534 views
- November 13, 2019
- 1
Top Ten Topics in Clinical Cardiology 2023
Subclinical & Clinical Atherosclerosis: Accelerated Epigenetic Age, Inflammation or Both?
FEATURING
Valentin Fuster
- 529 views
- November 8, 2023
- 5
Novartis Cardiology
Understanding Acquisition and Billing for a Non-Statin Lipid-Lowering Therapy
FEATURING
Bobbi Buell
- 523 views
- August 30, 2024
- 3
The Texas Heart Institute
Treatment-Risk Paradox in Blood Pressure Management
FEATURING
Joseph Diamond
- 512 views
- November 12, 2021
- 1
Houston Methodist DeBakey Heart and Vascular Center
Practical Tips for Managing CVD Risk Among High-Risk Diabetes
FEATURING
Michael Blaha
- 507 views
- October 18, 2021
- 5
ASPC 2018 Congress on CVD Prevention
PCSK9 Inhibitors Today - When, How, and In Whom
FEATURING
Jennifer Robinson
- 486 views
- August 10, 2018
- 3
Houston Methodist DeBakey Heart and Vascular Center
CVD Prevention Considerations Among Those With Low Testosterone
FEATURING
Matthew Budoff
- 486 views
- October 20, 2021
- 5
ASPC 2020 Virtual Summit on CVD Prevention
Integrating Imaging & Advanced Blood Testing for CVD Prevention/Management: How Do We Know If the Patient Is in Prediabetes Phase? Why Do Lipoproteins Become Atherogenic? What Is the Role of Non-Lifestyle Genetic Markers?
FEATURING
Arthur Agatston
- 483 views
- March 24, 2021
- 3
Meeting Pearls
Suggested Screening Timeframes and Treatment Options for Hypertension, Hypercholesterolemia, and Atherosclerosis
FEATURING
Shireen Hashmat
- 480 views
- July 14, 2021
- 1
Georgia Heart Institute
In Vivo Imaging of the Immune System for Health & Disease Assessment
FEATURING
Zahi Fayad
- 474 views
- May 9, 2023
- 2
The North American Thrombosis Forum (NATF)
Identifying Patients Who Would Benefit from PCSK9 Inhibitors
- 461 views
- January 26, 2023
- 1
Cardiology Fiesta 2018
The State of the Evidence in Severely Calcified Coronary Lesions
FEATURING
James Hermiller
- 456 views
- November 28, 2018
- 1
Georgia Heart Institute
Interview with Dr. Nehal Mehta, CCTA is the Future of Coronary Risk Stratification
FEATURING
Nehal N. Mehta
- 451 views
- June 21, 2022
- 4
Northwestern Medicine: 6th Annual Cardiovascular Update
Dyslipidemia: Who to Treat and When
FEATURING
Neil Stone
- 448 views
- December 11, 2018
- 3
Joel M. Gelfand
Improving Cardiovascular Screening in Patients With Psoriasis
- 438 views
- May 25, 2023
- 4